GRAIL Inc GRAL
NASDAQ · United States · Health Technology
$137.89-2.23 (-1.59%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -2.56 | -2.66 | +3.6% | $44.69M | +5.4% | -12.8%$72.70→$63.40 |
| Q1 2026 | 2026-05-05 | -1.37 | -1.96 | +30.1% | — | — | +12.7%$55.66→$62.75 |
| Q4 2025 | 2026-02-19 | -2.44 | -2.53 | +3.6% | — | — | -50.9%$102.28→$50.21 |
| Q3 2025 | 2025-11-12 | -2.46 | -3.26 | +24.5% | — | — | -0.2%$83.39→$83.20 |
| Q2 2025 | 2025-08-12 | -3.18 | -3.56 | +10.7% | — | — | — |
| Q1 2025 | 2025-05-13 | -3.10 | -3.80 | +18.4% | — | — | — |
| Q4 2024 | 2025-02-20 | -2.89 | -4.97 | +41.9% | — | — | — |
| Q3 2024 | 2024-11-12 | -3.50 | -6.43 | +45.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.